Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Retevmo
Pharma
ESMO: Lilly drug drives major benefits in lung, thyroid cancers
Eli Lilly's Retevmo showed it can offer dramatic tumor progression benefits in the treatment of certain lung and thyroid cancers.
Angus Liu
Oct 21, 2023 10:30am
Lilly shows Roche how it's done in thyroid cancer niche
Aug 22, 2023 10:51am
Lilly pressures Blueprint further with positive NSCLC readout
Aug 4, 2023 10:40am
Roche pulls a Gavreto cancer indication, citing unfeasible trial
Jul 5, 2023 12:16pm
Eli Lilly's Retevmo gets FDA nod to treat all RET cancer types
Sep 22, 2022 11:15am
Lilly guns for 'tissue agnostic' nod for Retevmo
Apr 11, 2021 2:30pm
